newsfilter
← Latest News
PR Newswire·

Valeo Pharma Provides Update on Private Payer Reimbursement for Enerzair® Breezhaler® and Atectura® Breezhaler®

Private payer health plan coverage in Canada for Enerzair Breezhaler and Atectura Breezhaler has reached 80% Reimbursement proceedings with publicly funded health plans ready to commence MONTREAL, June 1, 2021 /PRNewswire/ - Valeo Pharma Inc. (C